[Indications for statin therapy in patients with acute coronary syndrome of ischemic origin]

Related Experiment Video

Updated: Jun 3, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Riccardo Raddino1, Paolo Della Pina, Elio Gorga

  • 1Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale ed Applicata, Università degli Studi, Brescia. riccardo.raddino@libero.it

Giornale Italiano Di Cardiologia (2006)
|March 23, 2011
PubMed

Insights

Statins effectively treat acute coronary syndromes by lowering cholesterol, reducing mortality by 24%. Early statin therapy is recommended for myocardial infarction patients, improving outcomes.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Acute coronary syndromes (ACS) pose significant mortality risks.
  • Cardiovascular risk factor control is crucial for reducing mortality.
  • Cholesterol reduction is a primary therapeutic target in ACS management.

Purpose of the Study:

  • To evaluate the efficacy of statins in treating acute coronary syndromes.
  • To highlight the role of statins in reducing mortality post-ACS.
  • To review current guideline recommendations for statin use in ACS.

Main Methods:

  • Review of recent evidence and clinical trials on statin therapy in ACS.
  • Analysis of mortality reduction attributed to cardiovascular risk factor control and cholesterol lowering.
  • Examination of guideline recommendations for statin use in different ACS subtypes.

Main Results:

  • Statins demonstrate comparable efficacy to other treatments for ACS.
  • Cholesterol reduction via statins leads to a -24% decrease in total mortality.
  • Early statin administration is effective within weeks of an acute coronary event.

Conclusions:

  • Statins are a cornerstone therapy for acute coronary syndromes.
  • Aggressive cholesterol management with statins significantly reduces mortality.
  • Current guidelines strongly recommend statin use in non-ST-elevation myocardial infarction and ST-elevation myocardial infarction.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...